166 related articles for article (PubMed ID: 15995506)
1. Neck dissection followed by radiotherapy or chemoradiotherapy for small primary oropharynx carcinoma with cervical metastasis.
Reddy AN; Eisele DW; Forastiere AA; Lee DJ; Westra WH; Califano JA
Laryngoscope; 2005 Jul; 115(7):1196-200. PubMed ID: 15995506
[TBL] [Abstract][Full Text] [Related]
2. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
Garden AS; Asper JA; Morrison WH; Schechter NR; Glisson BS; Kies MS; Myers JN; Ang KK
Cancer; 2004 Mar; 100(6):1171-8. PubMed ID: 15022283
[TBL] [Abstract][Full Text] [Related]
3. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
[TBL] [Abstract][Full Text] [Related]
4. Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer.
Cupino A; Axelrod R; Anne PR; Sidhu K; Lavarino J; Kung B; Rosen M; Keane W; Machtay M
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):416-21. PubMed ID: 17765768
[TBL] [Abstract][Full Text] [Related]
5. Combined radiotherapy with planned neck dissection for small head and neck cancers with advanced cervical metastases.
Wang SJ; Wang MB; Yip H; Calcaterra TC
Laryngoscope; 2000 Nov; 110(11):1794-7. PubMed ID: 11081586
[TBL] [Abstract][Full Text] [Related]
6. Planned post-chemoradiation neck dissection: significance of radiation dose.
Stenson KM; Huo D; Blair E; Cohen EE; Argiris A; Haraf DJ; Vokes EE
Laryngoscope; 2006 Jan; 116(1):33-6. PubMed ID: 16481805
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx.
Moncrieff M; Sandilla J; Clark J; Clifford A; Shannon K; Gao K; O'Brien C
Laryngoscope; 2009 Feb; 119(2):307-11. PubMed ID: 19172611
[TBL] [Abstract][Full Text] [Related]
8. Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection?
Aslani M; Sultanem K; Voung T; Hier M; Niazi T; Shenouda G
Head Neck; 2007 Jun; 29(6):585-90. PubMed ID: 17274051
[TBL] [Abstract][Full Text] [Related]
9. Combined ipsilateral treatment of cervical lymph nodes metastases from an unknown primary.
Dequanter D; Lothaire P; Gastelblum P; Nguyen TH; Lalami Y; Awada A; Andry G
B-ENT; 2008; 4(3):157-61. PubMed ID: 18949962
[TBL] [Abstract][Full Text] [Related]
10. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
11. Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck.
Shehadeh NJ; Ensley JF; Kucuk O; Black C; Yoo GH; Jacobs J; Lin HS; Heilbrun LK; Smith D; Kim H
Head Neck; 2006 Dec; 28(12):1090-8. PubMed ID: 16933316
[TBL] [Abstract][Full Text] [Related]
12. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
15. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy.
Boscolo-Rizzo P; Gava A; Da Mosto MC
Ann Surg Oncol; 2007 May; 14(5):1575-82. PubMed ID: 17508250
[TBL] [Abstract][Full Text] [Related]
17. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
19. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
[TBL] [Abstract][Full Text] [Related]
20. Management of squamous cell carcinoma of unknown origin in cervical lymph nodes.
Mohit-Tabatabai MA; Dasmahapatra KS; Rush BF; Ohanian M
Am Surg; 1986 Mar; 52(3):152-4. PubMed ID: 3954261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
